Are People With Asthma at Greater Risk for Severe COVID-19?
Clinicians initially thought that people with asthma would have worse COVID-19 outcomes, but does current evidence support this theory?
Clinicians initially thought that people with asthma would have worse COVID-19 outcomes, but does current evidence support this theory?
A Chinese study explored the links between pediatric asthma, household pets, and domestic environmental factors such as mold.
A Dutch study examined the link between adult onset asthma, metabolic syndrome, and adipose tissue inflammatory markers, including IL-6 and the leptin-adiponectin ratio.
The combination therapy significantly reduced the risk of severe exacerbations and improved lung function.
The BLA submission included data from the pivotal phase 3 NAVIGATOR trial that assessed tezepelumab in 1061 patients with severe, uncontrolled asthma.
Data mining resulted in 2006 reports of anaphylaxis related to the use of 5 mAbs.
The novel ORACLE scale (Oxford Asthma Attack Risk Scale) demonstrated potential to predict — and subsequently prevent — asthma attacks using biomarkers of type 2 airway inflammation.
The BLA submission is supported by data from the PATHFINDER clinical program.
Airway symptoms may develop in menopausal women with no prior history of asthma following the initiation of hormone replacement therapy.
Although asthma and autoimmune disease are thought to have mutually exclusive pathogeneses, they both result from a dysregulated immune system.